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Abstract
Background—Calculating accurate estimates of cancer survival are important for various 
analyses of cancer patient care and prognosis. Current U.S. survival rates are estimated based on 
data from the National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results 
(SEER) program, covering approximately 28% of the U.S. population. The National Program of 
Cancer Registries (NPCR) covers about 96% of the U.S. population. Using a population-based 
database with greater U.S. population coverage to calculate survival rates at the national, state, and 
regional levels can further enhance the effective monitoring of cancer patient care and prognosis in 
the U.S. The first step is to establish the coding completeness and coding quality of the NPCR data 
needed for calculating survival rates and conducting related validation analyses.
Methods—Using data from the NPCR-Cancer Surveillance System (CSS) from 1995 through 
2008, we assessed coding completeness and quality on 26 data elements that are needed to 
calculate cancer relative survival estimates and conduct related analyses. Data elements evaluated 
consisted of demographic, follow-up, prognostic, and cancer identification variables. Analyses 
showing trends of these variables by diagnostic year, state of residence at diagnosis, and cancer 
site were performed.
Results—Mean overall percent coding completeness by each NPCR central cancer registry 
averaged across all data elements and diagnosis years ranged from 92.3% to 100%. Results 
showing the mean percent coding completeness for the relative survival-related variables in NPCR 
data are presented. All data elements but one have a mean coding completeness greater than 90% 
as was the mean completeness by data item group type. Statistically significant differences in 
coding completeness were found in the ICD revision number, cause of death, vital status, and date 
of last contact variables when comparing diagnosis years. The majority of data items had a coding 
quality greater than 90%, with exceptions found in cause of death, follow-up source, and the 
Surveillance, Epidemiology, and End Results (SEER) Summary Stage 1977, and SEER Summary 
Stage 2000.
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Conclusion—Percent coding completeness and quality are very high for variables in the NPCR-
CSS that are covariates to calculating relative survival. NPCR provides the opportunity to 
calculate relative survival that may be more generalizable to the U.S. population.
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Background
Estimation of cancer survival is an important part of assessing the overall strength of cancer 
care and success of prevention programs. Relative survival is a measure that can be used to 
describe the survival of a cohort of cancer patients by removing the effect of competing 
death events of a comparable general population. The measure is the ratio of observed 
survival among cancer patients divided by the expected survival of the general population 
that is comparable to the cancer patients with respect to covariates including age, sex, and 
year of diagnosis.1,2 Population-based cancer relative survival rates are important for 
medical and public health efforts, including measuring the survivorship of cancer patients 
after diagnosis and monitoring the impact of intervention and early detection programs.3
Current U.S. cancer survival rates are estimated based on data from the National Cancer 
Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) program, which 
covers approximately 28% of the U.S. population.4 The National Program of Cancer 
Registries (NPCR), established by Congress in 1992 and administered by the Centers for 
Disease Control and Prevention (CDC), is conducted in 45 states, the District of Columbia, 
Puerto Rico, and the Pacific Island Jurisdictions, and covers approximately 96% of the U.S. 
population. Data submitted annually to the NPCR-Cancer Surveillance System (NPCR-CSS) 
may also be used to calculate survival rates and provide greater coverage at national, 
regional, and state levels, so clinicians, public health practitioners, and researchers can 
effectively monitor cancer patient care and prognosis in the U.S.
NPCR-CSS collects data on the occurrence of cancer including the type, extent, and 
anatomic location of the cancer and the type of initial treatment by providing funding and 
technical assistance to the central cancer registries (CCRs) within the program.5 Population-
based CCRs are data systems that collect, manage, and analyze data about cancer cases. In 
each state, medical facilities (including hospitals, physicians’ offices, therapeutic radiation 
facilities, free-standing surgical centers, and pathology laboratories) are required to report 
demographic and clinically-related data to their central cancer registry. Each year, CDC 
supports efforts to link registry data with the National Death Index (NDI), Indian Health 
Service data, and state vital records, receives data from NPCR registries, and assesses the 
completeness and accuracy of the data.5 The annual data submissions from CCRs add a new 
year of data, update data from prior diagnosis years, and include the variables needed to 
calculate survival rates (e.g., age, sex, year of diagnosis, date of last contact) as well as 
variables that are important surrogates of the quality of the follow-up information obtained 
(e.g., type of reporting source, follow-up source, ICD revision number, cause of death) or 
can be used to stratify analyses (e.g., stage, county or state, race, ethnicity).
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Before using NPCR-CSS data to assess cancer survival, it is necessary to understand the 
coding completeness and coding quality of the data elements used in survival analyses 
across all the participating cancer registries. NPCR rigorously evaluates the completeness of 
case ascertainment and data quality for each annual data submission.3 Other studies have 
evaluated completeness, accuracy, and data quality of some, but not all, of the NPCR-CSS 
data required for conducting and validating survival analyses.6–10 For example, German and 
colleagues looked at the quality of breast and prostate cancer variables6; Hall and co-
workers compared SEER and NPCR incidence rates of cutaneous melanoma7; McDavid’s 
team assessed breast, prostate, and colon variables8; and Singh and co-workers investigated 
the quality of the census tract 2000 variable.9
Using 1998–2001 data from 34 CCRs, Thoburn and colleagues compared NPCR-CSS 
incidence data to medical record data for 13 data elements among 4 primary cancer sites 
(lungs/bronchus, colorectal, prostate, and female breast) to assess the case completeness and 
data accuracy.10 The elements investigated included date of birth, race, sex, state of 
residence at time of diagnosis, diagnosis date, primary site, histology, behavior, grade and 
SEER summary stage. The authors found data accuracy in 95% of the cases and case 
completeness in 96% of the cases; individual site-specific data element accuracy ranged 
from 81.2% to 100%, with a median accuracy of 98.1%.10
The purpose of the current study is to build upon these previous studies by evaluating the 
coding completeness and quality of 26 data elements, for all primary cancer sites, that are 
covariates to survival calculations and those used to assess the calculations across the 46 
funded CCRs.
Materials and Methods
Using NPCR-CSS data from 46 CCRs inclusive of 1995 through 2008 diagnosis years, 26 
data elements used in survival calculations and validation were examined for coding 
completeness and quality. Coding completeness was assessed by calculating the proportion 
of non-missing values by data element and by central registry; the numerator was the 
number of non-missing values and the denominator was the total number of values (Table 
1). Coding quality was calculated through the proportion of known values; the numerator 
was the number of known values (excluding unknown or blank values) and the denominator 
was the total number of values (Table 1).
The data elements consisted of survival analysis variables, demographic variables, cancer 
identification variables, follow-up and death variables, and cancer stage and prognostic 
variables. They specifically included:
Survival analysis: date of birth, date of diagnosis, date of last contact/death, and sex;
Demographics: age at diagnosis, U.S. state of residence, county of residence at diagnosis, 
race, ethnicity (Hispanic), Indian Health Service (IHS) linkage (used to better classify cases 
of American Indian/Alaska Native heritage), North American Association of Central Cancer 
Registries’ (NAACCR) Hispanic Identification Algorithm (NHIA) derived Hispanic origin 
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and NAACCR Asian/Pacific Islander Identification Algorithm (or NAPIIA, which is used to 
better classify cases of Asian Pacific Islander origin);
Cancer identification: behavior (benign, in situ, or malignant), diagnostic confirmation, 
histology, SEER primary site group, sequence number central (number of primary cancers), 
and type of reporting source (primary source from which original cancer incidence report 
received);
Follow-up, recurrence, and death: cause of death code, follow-up source central (2006–
2008 diagnosis years for which the variable was captured by CCRs), follow-up source 
(1995–2005 diagnosis years for which the variable was captured by CCRs) (source from 
which follow-up information received), International Classification of Diseases (ICD) 
revision number (cause of death coding system version; in the analyses this variable was 
divided into separate groups as versions 7–9 and version 10 or combined into 1 variable, 
versions 7–10), and vital status;
Cancer stage and prognostic: SEER summary stage 1977 (1995–2000 diagnosis years for 
which the variable was in use), SEER summary stage 2000 (2001–2003 diagnosis years for 
which the variable was in use), and collaborative stage (CS) derived SEER summary stage 
2000 (2004–2008 diagnosis years for which the variable was in use).
The mean percent coding completeness for each of the 46 central cancer registries was 
calculated and averaged over the 26 data elements combined and all diagnosis years (1995–
2008) combined; the mean percent coding completeness was also calculated for each of the 
26 data elements averaged over all the diagnosis years combined and all central cancer 
registries combined. Mean percent coding quality was assessed by each of the 26 data 
elements, taking the average of all diagnosis years and all central cancer registries 
combined. General linear modeling was performed to assess statistical differences for each 
data element by diagnosis year (year was coded as a categorical variable; the latest year 
available, 2008, was used as the referent year) and NPCR central cancer registry (assessed 
individually; the referent variable was a state that has maintained high coding quality and 
stability over time) (α=0.05). Coding completeness of each data element was modeled as the 
outcome variable with diagnosis year and NPCR central cancer registry as the independent 
variables, respectively, in a least squares linear model. All analyses were conducted using 
SAS (version 9.2, SAS Institute, Inc., Cary, NC).
Results
Coding Completeness
The mean overall coding completeness by each NPCR central cancer registry averaged 
across all 26 data elements and all diagnosis years ranged from 92.3% to 100% (Figure 1). 
Twenty-one of the central cancer registries (46%) had a mean overall coding completeness 
greater than or equal to 99% (Figure 1). All, but one, of the 26 data elements’ mean coding 
completeness by combined diagnosis year was greater than 90%; the completeness for the 
elements ranged from 91.9% to 100% (Table 2). Follow-up source (1995–2005) had a mean 
completeness of 42.2% (Table 2). Similarly, the data elements’ mean coding completeness 
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by all central cancer registries combined was high; the majority ranged from 96.8% to 100% 
(Table 2). Only two of the elements were lower than that range: mean coding completeness 
by central cancer registry for Indian Health Service linkage was 88.9% and follow-up source 
(1995–2005) was 64.9% (Table 2). When we examined the data elements grouped by 
variable type, the mean coding completeness was above 90% for each group; 99.3% over the 
4 survival analysis variables combined, 98.6% over the 8 demographic variables, 100% over 
the 6 cancer identification data elements combined, 92.1% for the 5 follow-up/death data 
elements, and 100% for the 3 cancer stage/prognostic (not shown in tables).
In assessing the statistical difference in mean coding completeness of each data element by 
diagnosis year through the general linear models procedure, we found that date of birth, 
SEER summary stage 2000, CS derived SEER summary stage 2000, SEER summary stage 
1977, cause of death, and follow-up source (2006–2008) showed no statistically significant 
differences by diagnosis year (Table 3). For ICD revision number, there was statistically 
significant difference comparing 2008 to 1996, but there were no statistically significant 
differences for the other diagnosis years. The mean coding completeness rates for the vital 
status data element are statistically significantly different comparing 2008 to the thirteen 
years, 1995 through2007 diagnosis years. Date of last contact’s coding completeness rates 
for 1995 and 2000–2003 were significantly different compared to 2008.
We also found that the percent coding completeness for the follow-up source variable for 20 
NPCR central cancer registries were less than and statistically significantly different from 
the remaining NPCR central cancer registries (Table 3). For variables ICD revision number, 
date of birth, cause of death, and SEER summary stage 2000, only one central cancer 
registry has a less than statistically significant difference in mean coding completeness 
percent for each of these data elements. CS derived SEER summary stage 2000, IHS 
linkage, SEER summary stage 1977, vital status, follow-up source central, and date of last 
contact/death data elements all had two central cancer registries with a less than mean 
coding completeness percent statistically significantly different from all other NPCR central 
cancer registries.
Coding Quality
All of the survival analysis variables (date of birth, date of diagnosis, date last contact/death, 
and sex) achieved 100% coding quality (Figure 2). The majority of other variables also had 
a mean percent coding quality greater than 90%. The exceptions to this high percent were: 
cause of death (78% ICD versions 7, 8, or 9 and 81% ICD version 10), follow-up source 
(1995–2005) (33%), SEER Summary Stage 1977 (85%), and SEER Summary Stage 2000 
(87%).
Discussion
The results show a high level of coding completeness and quality for the 4 survival analysis 
variables (date of diagnosis, date of birth, date of last contact or death, and sex) across 
central cancer registry sites and diagnosis years. The majority of variables used to assess 
quality of the follow-up information and to stratify analyses also had high averaged means 
of coding completeness and quality by central registry sites and diagnosis years. These 
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findings may be indicative of the training and support CDC NPCR provides in monitoring 
and improving coding completeness.
The mean coding completeness percent for the relative survival data elements examined is 
relatively high, compared with the previous studies,6–10 with an increase in the 2006 
diagnosis year, and is similar among NPCR CCRs. This increase may result from the 
increase in NPCR CCRs conducting linkage processes with the National Death Index (NDI), 
including additional data editing and record updating, as well as the availability of training 
sessions and other resources. Demographic (some of which are evaluated annually to 
determine compliance with NPCR Program Standards), cancer identification, cancer stage/
prognostic, and the majority of the follow-up/death data elements have high mean coding 
completeness percentages.
Even though the results are very promising, additional work may be needed for some of the 
data elements (e.g., date of last contact/death, follow-up source, IHS linkage). Some NPCR 
central cancer registries have concerns releasing the full date of last contact/death due to 
confidentiality while other central cancer registries may not be updating this data element 
following death certificate clearance procedures and/or NDI linkages. Additional 
discussions to assure confidentiality or resources to facilitate automatic record updates may 
be needed to improve the completeness of date of last contact /death. Our analysis also 
showed how competing priorities can affect coding completeness, as exhibited with the date 
of last contact/death variable. Starting in 2001, NPCR established a linkage agreement with 
NDI, which facilitated improved linkages and date of last contact/death information. 
However, in 2004, when Collaborative Stage activities became a priority for CCRs, the 
linkages were not completed as frequently and the completeness of the variable was 
affected.
The data element follow-up source (1995–2005 diagnosis years) has not been required by 
CDC for the NPCR registries, so the low level of completeness is not surprising. However, 
this data element is important; it makes it possible to identify records with information 
resulting from NDI linkages and, when necessary, release of that information can be 
recorded and reported back to NDI. The data item can also serve as a surrogate for the 
quality of the follow-up information.
As shown in the Results, the cause of death variable has a low percent of coding quality, 
78% and 81% for the different ICD versions. The cause of death is dependent upon 
information recorded on death certificates, available through vital statistics linkages, and 
data quality issues have been identified in other evaluations. For this reason, researchers 
generally rely on relative survival rates for cancer rather than cause-specific survival rates.
Not all NPCR CCRs link with the IHS Administrative database on an annual basis, but all 
do link every 5 years. If a record is not sent for IHS Administrative database linkage, this 
data element is not coded. This most likely explains the lower percent completeness for the 
IHS linkage variable. Additional analyses may be needed, limiting the analyses to only those 
CCRs that conduct the IHS linkage annually or to the years where all CCRs conduct the 
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linkage. The coding quality evaluation, however, showed that for records that were sent for 
linkage, the percent with a coded known value is very high.
Our results show that the NPCR-CSS data can be a complete source of information for 
researchers interested in using population-based cancer data to study cancer relative survival 
in the U.S. Another strength of the NPCR data is the potential to calculate relative survival 
by race and ethnicity, which may assist researchers and comprehensive cancer control 
coalitions in making decisions about the type of cancer care and cancer programs they 
provide to the various ethnicities in the U.S., thereby having the potential to reduce 
disparities in cancer incidence and survival.
More work is needed to improve coding completeness for cancer case follow-up, the 
information with the lowest mean coding completeness percentages in this database. A 
limitation of this study is that we did not assess data accuracy for these relative survival 
variables. Evaluating the data accuracy requires an audit of the source documents and the 
assigned codes. Other projects are conducting this evaluation and include some, but not all, 
of the data elements assessed in this project.
Survival analysis estimates are critical for many prevention, control, and treatment activities, 
including evaluation of the impact of screening and comprehensive cancer control programs 
and assessing the progress in cancer treatments. Because NPCR provides data for 
approximately 96% of the U.S. population, it has the potential to provide near-national 
estimates as well as regional and state-based measures that have not before been available to 
researchers, clinicians, and public health decision makers. Our analyses demonstrate the 
high coding completeness and quality of the NPRC-CSS variables that are needed to 
calculate relative survival estimates and variables used to validate and stratify the estimates.
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Figure 1. 
Mean Percent Coding Completeness Averaged Over All Data Elements Combined (n=26) 
and Over All Diagnosis Years Combined (1995–2008) by National Program of Cancer 
Registries (NPCR) Central Cancer Registry (n=46).
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Figure 2. 
Mean Percent Coding Quality of Known Value for Relative Survival Data Elements 
Averaged Over All Diagnosis Years (1995–2008) and Over All NPCR Central Cancer 
Registries (n=46) Data
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Table 1
Coding Completeness and Coding Quality: Example Using the County of Residence Variable
County of Residence at Diagnosis – Codes
Coding Completeness Coding Quality
Numerator 000, 001–840, 999 001–840
Denominator 000, 001–840, 999, invalid/blank 000, 001–840, 999, invalid/blank
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Table 2
Mean Percent Coding Completeness for Relative Survival Data Elements Averaged Over All Diagnosis Years 
(1995–2008) and Over All National Program of Cancer Registries (NPCR) Central Cancer Registries (n=46), 
NPCR Data
Mean Coding Completeness
Data Elements By Diagnosis Years
Combined (1995–2008)
(%) [range]
By All NPCR Central
Cancer Registries (n=46)
(%) [range]
Survival Analysis Variables
  Date of birth 99.9 [99.8–100] 99.9 [98.9–100]
  Date of diagnosis 100 [−] 100 [−]
  Date of last contact or death 96.2 [95.3–98.2] 97.1 [47.4–100]
  Sex 100 [−] 100 [−]
Demographic variables
  Age at diagnosis 100 [−] 100 [−]
  County of residence at diagnosis 100 [−] 100 [−]
  Ethnicity (Hispanic) 100 [−] 100 [−]
  Indian Health Service linkage 91.9 [72.6–98.0] 88.9 [59.8–100]
  NHIA (Hispanic origin) 99.3 [99.0–99.6] 100 [−]
  NAPIIA (Asian Pacific Islander origin)
  Race 100 [−] 100 [−]
  State of residence at diagnosis 100 [−] 100 [−]
Cancer identification variables
  Behavior 100 [−] 100 [−]
  Diagnostic confirmation 100 [−] 100 [−]
  Histology 100 [−] 100 [−]
  SEER primary site group 100 [−] 100 [−]
  Number of primary cancers 100 [−] 100 [−]
  Type of reporting source 100 [−] 100 [−]
Follow-up/recurrence/death variables
  Cause of death (ICD v.7–10) 99.7 [99.2–99.9] 99.6 [91.4–100]
  Follow-up source (1995–2005) 42.2 [38.5–43.6] 64.9 [0–100]
  Follow-up source (2006–2008) 98.0 [97.5–98.7] 96.8 [9.6–100]
  ICD revision number 99.8 [99.2–100] 99.9 [94.8–100]
  Vital status 99.5 [94.9–100] 99.8 [98.9–100]
Cancer stage/prognostic variables
  SEER Summary Stage 1977 (1995–2000) 100 [−] 100 [−]
  SEER Summary Stage 2000 (2001–2003) 100 [−] 100 [99.2–100]
  SEER Summary Stage 2000 (CS derived) (2004–2009) 100 [−] 100 [99.9–100]
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Table 3
General linear models procedure (GLM) to assess percent mean coding completeness differences for relative 
survival data elements by diagnosis year and by NPCR central cancer registry using NPCR-CSS data (1995–
2008)
Data Elements
Diagnosis Year NPCR Central Cancer
Registry (CCR) ***
Statistical
Difference**
p-value* Statistical
Difference**
p-
value*
Survival analysis variables
  Date of birth NSD 1 NPCR CCR SD from all 
other NPCR CCRs
<0.0001
  Date of diagnosis NSD NSD
  Date of last contact or death 2008 SD from 1995, 
2000 – 2003
2008 NSD from 1996 – 
1999, 2004 – 2007
0.02 (1995)
0.04 (2000)
0.02 (2001)
0.02 (2002)
0.03 (2003)
2 NPCR CCRs SD from all 
other NPCR CCRs
<0.01
<0.01
  Sex NSD NSD
Demographic variables
  Age at diagnosis NSD NSD
  County of residence at diagnosis NSD NSD
  Ethnicity (Hispanic) NSD NSD
  Indian Health Service linkage 2008 SD from 1995 – 
2002
2008 NSD from 2003 – 
2007
0.03 (1995)
0.04 (1996–2002)
2 NPCR CCRs SD from all 
other NPCR CCRs
<0.01
<0.01
  NHIA (Hispanic origin) 2008 SD from 1995 0.01 (1995) NSD
  NAPIIA (Asian Pacific Islander origin)
  Race NSD NSD
  State of residence at diagnosis NSD NSD
Cancer identification variables
  Behavior NSD NSD
  Diagnosis confirmation NSD NSD
  Histology NSD NSD
  SEER primary site group NSD NSD
  Number of primary cancers NSD NSD
  Type of reporting source NSD NSD
Follow-up/recurrence/death variables
  Cause of death (ICD v.7–10) NSD 1 NPCR CCR SD from all 
other NPCR CCRs
<0.0001
  Follow-up source (1995–2005) 2005 NSD from other 
diagnosis years
20 NPCR CCRs SD from all 
other NPCR CCRs
  Follow-up source (2006–2008) NSD 2 NPCR CCRs SD from all 
other NPCR CCRs
<0.01
<0.02
  ICD revision number 2008 SD from 1996
2008 NSD from other 
diagnosis years
0.04 (1996) 1 NPCR CCR SD from all 
other NPCR CCRs
<0.0001
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Data Elements
Diagnosis Year NPCR Central Cancer
Registry (CCR) ***
Statistical
Difference**
p-value* Statistical
Difference**
p-
value*
  Vital status 2008 SD from 1995–
2007
0.02 (1995–2007) 2 NPCR CCRs SD from all 
other NPCR CCRs
<0.01
<0.01
Cancer stage/prognostic variables
  SEER Summary Stage 1977 (1995–2000) NSD 2 NPCR CCRs SD from all 
other NPCR CCRs
<0.01
<0.01
  SEER Summary Stage 2000 (2001–2003) NSD 1 NPCR CCR SD from all 
other NPCR CCRs
<0.0001
  SEER Summary Stage 2000 (CS derived) (2004–
2009)
NSD 2 NPCR CCRs SD from all 
other NPCR CCRs
<0.01
<0.01
*p-value calculated at alpha = 0.05 level of significance
**SD – statistically significant difference; NSD – no statistically significant difference
***Statistically significant NPCR Central Cancer Registries all had a mean completeness less than that of the referent NPCR Central Cancer 
Registry
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